Found 6414 matches for
Largest genome-wide study of parasite provides clearest picture yet of genetic changes driving artemisinin resistance artemisinin-genetics-resistance. Hinxton, Cambridge, UK, 19 January 2015 – The largest genome-wide association study to date of the malaria parasite Plasmodium falciparum unveils a complex genetic architecture that enables the parasite to develop resistance to our most effective antimalarial drug, artemisinin.
Excel spread sheet that summarises the 6 randomised controlled trials upon which the WHO COVID-19 guidelines on chemoprophylaxis are based. Glossary: Glossary HCQ: hydroxychloroquine, OD: daily, OW: once weekly, AE: adverse effect
Medical Product Quality Report COVID-19 VACCINE issues. Up to 31 May 2021
Medical Product Quality Report COVID-19 VACCINE issues. Up to 30 April 2021
Medical Product Quality Report COVID-19 VACCINE issues.Up to 31 March 2021
Medical Product Quality Report - Covid 19 Issues Issue 9 for February 2021
March 2021 issue of the Medical Product Quality Report - COVID-19 vaccine. COVID-19 vaccines are vital interventions to help end the pandemic. However, with severe issues with equitable global access, falsified, diverted and substandard (especially degraded) vaccines are highly likely to become increasing global public health problems, leading to vulnerable communities thinking that they are protected when they are not. In order to facilitate our understanding of such reports and to inform interventions, we summarise reports in the public domain relevant to substandard and falsified (SF) COVID-19 vaccines since the start of the pandemic.
Following WHO recommendations against the use of hydroxychloroquine in the prevention of COVID-19, including its use in controlled trials, we are reviewing the guideline and the available evidence. We are concerned that this judgement from the authors of the guideline is scientifically unsound.
Medical Product Quality Report_Covid-19 Issues_Issue 7 December 2020_Main text only_V1
Medical Product Quality Report_Covid-19 Issues_Issue 7 December 2020_Main text plus annexes_V1
Medical Product Quality Report_Covid-19 Issues_Issue 6 November 2020_Main text only_V1
Medical Product Quality Report_Covid-19 Issues_Issue 6 November 2020_Main text plus annexes_V1.
Medical Product Quality Report_Covid-19 Issues_Issue 5 October 2020_Main text plus annexes
Medical Product Quality Report_Covid-19 Issues_Issue 5 October 2020_Main text